A consumer demand or subjective value approach to government-provided or -subsidized medical services. The usual cost/benefit or human capital approach is irrelevant to human preferences and actions of decisionmakers. For the nonpoor, government action should generally be restricted to what consumers cannot obtain elsewhere: regulatory actions, control of infectious diseases and pollution, and aid to biomedical research. Government activities are worth what people would be willing to pay for them. Services to those who could not pay are justified by the willingness of the nonpoor to pay for them. Giving the poor what they want instead of what some index says they need would better serve the total perceived well-being, since present programs arouse hostility. Direct money transfers to the poor cost far less to deliver than medical services and would probably contribute more to improving health through better living conditions. 38 pp. Ref.
This report is part of the RAND Corporation Paper series. The paper was a product of the RAND Corporation from 1948 to 2003 that captured speeches, memorials, and derivative research, usually prepared on authors' own time and meant to be the scholarly or scientific contribution of individual authors to their professional fields. Papers were less formal than reports and did not require rigorous peer review.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.